AIM ImmunoTech Announces Commencement of Phase 2 Study of Ampligen® for[...]
08/03/2022 | Press release | Distributed by Public on 08/03/2022 14:04
Please select the service you want to use:
Smartlinks | SunRun Inc. | Company News | Energy | Renewable Energy Industry | Lifestyle and Leisure | Leisure | Public Companies | Photovoltaic and Solar Equipment Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact